GGrantIndex
← Leaderboards

Gina Marie Peloso

Massachusetts General Hospital

$4,459,562
Attributed
$8,176,545
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,176,545 · 4

By mechanism

R01$7,433,966 · 2
K01$561,949 · 1
R03$180,630 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Coronary Heart Disease

Research focus

Coronary Heart DiseasePhenotypeLipidsPlasmaGenotypeLdl Cholesterol LipoproteinsVariantGenetic AnalysisTriglyceridesGenesHeart Disease RiskAllelesGeneticGenomicsInsightBiologicalCholesterolLeadershipPublic Health RelevanceCardiovascular SystemCause Of DeathCodeGenetic VariantMedicine

Grant awards (18)

Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias$640,750
R01 · FY2025 · HL
Using genetic variation to study biology of blood lipids & coronary heart disease$730,677
R01 · FY2024 · HL · contact PI
Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias$697,700
R01 · FY2024 · HL
Using genetic variation to study biology of blood lipids & coronary heart disease$746,085
R01 · FY2023 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$530,006
R01 · FY2023 · HL
Using genetic variation to study biology of blood lipids & coronary heart disease$278,223
R01 · FY2023 · HL · contact PI
Using genetic variation to study biology of blood lipids & coronary heart disease$748,631
R01 · FY2022 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$532,819
R01 · FY2022 · HL
Using genetic variation to study biology of blood lipids & coronary heart disease$821,176
R01 · FY2021 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$543,747
R01 · FY2021 · HL
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$544,954
R01 · FY2020 · HL
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$619,198
R01 · FY2019 · HL
Genetic determinants of triglyceride-rich lipoproteins to disentangle CHD risk$90,354
R03 · FY2019 · HL · contact PI
Discovering lipoprotein lipase pathway variants that protect against CHD$140,253
K01 · FY2018 · HL · contact PI
Genetic determinants of triglyceride-rich lipoproteins to disentangle CHD risk$90,276
R03 · FY2018 · HL · contact PI
Discovering lipoprotein lipase pathway variants that protect against CHD$144,274
K01 · FY2017 · HL · contact PI
Discovering lipoprotein lipase pathway variants that protect against CHD$140,802
K01 · FY2016 · HL · contact PI
Discovering lipoprotein lipase pathway variants that protect against CHD$136,620
K01 · FY2015 · HL · contact PI